openPR Logo
Press release

Antidepressant Drugs Market to Witness Astonishing Growth by 2029

09-25-2023 08:07 AM CET | Health & Medicine

Press release from: Orion Market Research

Antidepressant Drugs Market to Witness Astonishing Growth

The global antidepressant drug market is expected to grow at a significant CAGR during the forecast period. Antidepressants are used for the treatment of all age group patients suffering from clinical and anxiety depression and are further used for regulating mood. As per the Centers for Disease Control and Prevention (CDC), during the period, 2011-2014, 12.7% of people aged 12 and overtook antidepressant medication. This, in turn, reflects the increasing demand for antidepressant drugs in the market. 

Based on the drug class, the antidepressant drugs market is segmented into selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), atypical antidepressants, monoamine oxidase inhibitors (MAOIs), and other medications. SSRIs segment held a significant share in the global antidepressant drug market.

SSRIs aim to relieve symptoms that work by blocking the reuptake, or reabsorption, of serotonin by some brain nerve cells. It increases the serotonin level in the brain, which improves mood. SSRIs drugs include sertraline, escitalopram, citalopram, fluoxetine, and paroxetine, usually produced at least side effects, as compared to tricyclic antidepressants. The common side effects of these drugs comprise sexual dysfunction, sleepiness or insomnia, and weight gain.  These types of drugs are considered a potential treatment for all kinds of anxiety disorders; however, the treatment of OCD normally requires higher doses.

SNRIs class include duloxetine and venlafaxine, which is known for its dual mechanism of action, such as enhancing the levels of the norepinephrine and neurotransmitters serotonin by constraining their reabsorption into brain cells. Like other medications, its possible side effects include a minor increase in blood pressure, headache, stomach upset, insomnia, sexual dysfunction, and weight gain. Such medications are considered as potential as SSRIs, and therefore, it is also considered as a first-line treatment to treat anxiety disorders. However, it is not preferred for OCD, where SSRIs are usually chosen as a first-line treatment.

However, antidepressants may trigger hypomania or mania in some people. If the patient stops taking the antidepressant, it can worsen bipolar symptoms. In this case, the patient may be given a new diagnosis and different medication. Several other side-effects that are associated with antidepressants include neuroleptic malignant syndrome, suicidal feelings, SIADH (Syndrome of Inappropriate Antidiuretic Hormone Secretion), and serotonin syndrome. Due to these concerns, major pharmaceutical companies, including GSK, AstraZeneca, Pfizer, Merck, and Sanofi slowed researches on new antidepressants altogether. This, in turn, results in slowing down the adoption rate and the overall antidepressant drug market.

To Request a Sample of our Report on Antidepressant Drugs Market:  https://www.omrglobal.com/request-sample/antidepressant-drugs-market

Antidepressant Drugs Market - Segmentation

By Depressive Disorder

Major Depressive Disorder (MDD)
Obsessive-compulsive Disorder (OCD)
Generalized Anxiety Disorder (GAD)
Panic Disorder (PD)
Other Depressive Disorders

By Drug Class

Selective Serotonin Reuptake Inhibitors (SSRIs)
Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
Atypical Antidepressants
Monoamine Oxidase Inhibitors (MAOIs)
Other Medications

A full Report of Antidepressant Drugs Market is Available @   https://www.omrglobal.com/industry-reports/antidepressant-drugs-market

Antidepressant Drugs Market - Segmentation by Region

North America

United States
Canada

Europe

UK
Germany
Spain
France
Italy
Rest of Europe

Asia-Pacific

India
China
Japan
South Korea
Rest of APAC

Rest of the World

Latin America 
Middle East & Africa

Company Profiles

Alkermes Plc
Allergan PLC
Breckenridge Pharmaceutical, Inc.
AstraZeneca Plc
Bristol Myers Squibb Co.
Camber Pharmaceutical Inc.
Eli Lilly & Co.
GlaxoSmithKline Plc
Lundbeck A/S
Intellipharmaceutics International Inc.
Johnson & Johnson Services Inc.
Merck & Co., Inc.
Mylan N.V.
Novartis International AG
Pfizer Inc.
Sanofi S.A.
Sun Pharmaceuticals Ltd.
Takeda Pharmaceutical Co.
Teva Pharmaceutical Industries Ltd.

Reasons to buy from us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

https://www.somosxbox.com.mx/noticias-urgente/se-preve-que-el-valor-de-mercado-de-los-sensores-activos-de-ruedas-de-ferrocarril-se-amplie-para-2029/112058/
https://perualdia.net/el-mercado-de-poliamidas-sinteticas-y-de-base-biologica-generara-ingresos-record-para-2029-2/
https://ekz-crosstour.ch/news/der-markt-fuer-spezialenzyme-aus-mikroorganismen-wird-bis-2029-ein-erstaunliches-wachstum-verzeichnen/118113/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

About Orion Market Research 
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antidepressant Drugs Market to Witness Astonishing Growth by 2029 here

News-ID: 3221016 • Views:

More Releases from Orion Market Research

Terahertz Technology Market Set to Witness Significant Growth by 2032 | TOPTICA Photonics AG, Advantest Corporation, Batop GmbH
Terahertz Technology Market Set to Witness Significant Growth by 2032 | TOPTICA …
The Terahertz Technology Market was valued at approximately USD 1.09 billion in 2024 and is projected to reach USD 4.08 billion by 2032, reflecting a compound annual growth rate (CAGR) of 18.1% from 2025 to 2032. Terahertz Technology Market Overview Terahertz (THz) technology operates in the electromagnetic spectrum between microwave and infrared waves, encompassing frequencies from 0.1 to 10 THz. This technology is gaining prominence due to its non-ionizing radiation, enabling
Specialty Tapes Market Set to Witness Significant Growth by 2032 | Avery Dennison Corporation, Scapa Group Plc, Intertape Polymer Group
Specialty Tapes Market Set to Witness Significant Growth by 2032 | Avery Denniso …
The global Specialty Tapes Market was valued at approximately USD 55.39 billion in 2023 and is projected to reach USD 96.3 billion by 2032, reflecting a compound annual growth rate (CAGR) of 6.3% from 2024 to 2032. Specialty Tapes Market Overview The Specialty Tapes Market encompasses a diverse range of adhesive products tailored for specific applications across various industries. These tapes are characterized by their unique properties, such as high temperature
Safety Helmets Market Set to Witness Significant Growth by 2033 | MSA Safety, Uvex Safety Group, Delta Plus Group, Bullard, Schuberth GmbH
Safety Helmets Market Set to Witness Significant Growth by 2033 | MSA Safety, Uv …
The global Safety Helmets Market was valued at approximately USD 5.01 billion in 2024, and it is expected to reach around USD 9.76 billion by 2033, growing at a *compound annual growth rate (CAGR) of about 7.7% from 2025 to 2033. Safety Helmets Market Overview The Safety Helmets Market is gaining momentum as industries like construction, manufacturing, mining, and infrastructure increasingly emphasize worker safety and regulatory compliance. Safety helmets-designed to protect against
Sales Performance Management Market Gaining Momentum by 2033 | Xactly Corporation, Anaplan Inc., IBM Corporation, Varicent Software Inc.
Sales Performance Management Market Gaining Momentum by 2033 | Xactly Corporatio …
The global Sales Performance Management market was valued at approximately USD 5.62 billion in 2024 and is projected to grow to about USD 18.22 billion by 2033, with a compound annual growth rate (CAGR) of approximately 13.27% between 2025 and 2033. Sales Performance Management Market Overview Sales Performance Management integrates tools and processes designed to boost sales productivity, optimize incentive structures, and align field sales efforts with business goals. Today's market is

All 5 Releases


More Releases for Antidepressant

Antidepressant Drugs Market is Dazzling Worldwide and Forecast to 2031
The global antidepressant drug market is expected to grow at a significant CAGR during the forecast period. Antidepressants are used for the treatment of all age group patients suffering from clinical and anxiety depression and are further used for regulating mood. As per the Centers for Disease Control and Prevention (CDC), during the period, 2011-2014, 12.7% of people aged 12 and overtook antidepressant medication. This, in turn, reflects the increasing
Antidepressant Drugs Market to Encounter Countless Growth Opportunities by 2028
The depression is the mood disorder that give a continue feeling of sadness and loss of interest. There are many factors which leads to the depression such as inherited traits, hormones, stress, brain chemistry which can cause the depression. The antidepressants help to maintain the balance between the brain chemistry and hormonal changes which is used for treatment of depression. Depression require long time of treatment it can be treated
Stakeholders: Antidepressant Drugs Market boom in Coming Year
The global antidepressant drugs market is estimated to surpass $18,762.4 million by 2027, exhibiting a CAGR of 2.9% from 2020 to 2027. OFFERINGS OF THE REPORT: The report offers comprehensive analysis of the global antidepressant drugs market by thoroughly studying different aspects of the market including major segments, market statistics, market dynamics, regional market outlook, investment opportunities, and top players working towards the growth of the market. The report also sheds light on
Antidepressant Drugs Market Analysis and Advancements Outlook 2019 - 2025
The report titled "Antidepressant Drugs Market" report will be very useful to get a stronger and effective business outlook. It provides an in-depth analysis of different attributes of industries such as trends, SWOT analysis, policies, and clients operating in several regions. The qualitative and quantitative analysis techniques have been used by analysts to provide accurate and applicable data to the readers, business owners and industry experts. The Antidepressant Drugs market was
Antidepressant Drugs market ready to register a 3.12 % CAGR
Actual Numbers & In-Depth Analysis, Business opportunities, Market Size Estimation Available in Full Report. Executive Summary -: A comprehensive research report that analyses the Antidepressant Drugs Market and the drugs market by Class - Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Benzodiazepines, Antipsychotics and Novel Agents, the report also assesses the sales of antidepressant drugs by sales channels - Hospital & Clinics, Retail Pharmacies, Others. A
Tricyclic Antidepressant Global Industry Report - History, Present and Future 20 …
GET SAMPLE REPORT @ https://www.research2reports.com/sample-report-chemical/tricyclic-antidepressant-market/71820 The global market size of Tricyclic Antidepressant is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand,